Raf inhibitors for the treatment of thyroid cancer

Details for Australian Patent Application No. 2008256922 (hide)

Owner Novartis AG

Inventors Stuart, Darrin Douglas

Agent Davies Collison Cave

Pub. Number AU-B-2008256922

PCT Pub. Number WO2008/147782

Priority 60/939,625 23.05.07 US

Filing date 21 May 2008

Wipo publication date 4 December 2008

Acceptance publication date 28 July 2011

International Classifications

A61K 31/4439 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 November 2009 PCT application entered the National Phase

  PCT publication WO2008/147782 Priority application(s): WO2008/147782

28 July 2011 Application Accepted

  Published as AU-B-2008256922

24 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008256926-((Bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists

2008256921-Hydrocarbon-producing genes and methods of their use